Nephron 503B Outsourcing Facility, a division of Nephron Pharmaceuticals Corp., a company focused on resolving drug shortage concerns, announced the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.

The following medications are readily available for order through the Nephron online ordering portal:

• 0.5% Albuterol 25 mg/5 mL (5 mg/mL) Preservative Free
• del Nido Cardioplegia Solution 1000 mL
• Lidocaine Injection Vial, USP 1% 50 mg/5 mL (10 mg/mL) Preservative Free
• Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) Preservative Free

“As a nationwide leader in manufacturing lifesaving medication, we work hard every single day to help the federal government alleviate drug shortages – and to deliver hospitals and patients the treatments they deserve and expect in a timely manner,” said Lou Kennedy, CEO and Owner of Nephron. “Playing this vital role in manufacturing is all the motivation we need to do our jobs well – and stay focused on precisely what it takes to raise the bar not only for our team, but for manufacturers everywhere.”

Nephron provides sterile pharmaceutical manufacturing and operates a 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America.